FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

373692009: Substance with phosphodiesterase inhibitor mechanism of action (substance)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1212151018 Phosphodiesterase inhibitor en Synonym Active Entire term case insensitive SNOMED CT core module
3520795018 Substance with phosphodiesterase inhibitor mechanism of action (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3520964015 Substance with phosphodiesterase inhibitor mechanism of action en Synonym Active Entire term case insensitive SNOMED CT core module

38 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Substance with phosphodiesterase inhibitor mechanism of action Is a Inotropic agent false Inferred relationship Existential restriction modifier
Substance with phosphodiesterase inhibitor mechanism of action Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Substance with phosphodiesterase inhibitor mechanism of action Is a Substance with hydrolase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Substance with phosphodiesterase inhibitor mechanism of action Has disposition Phosphodiesterase inhibitor true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing aspirin and butalbital and caffeine Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline hydrate 350mg modified-release tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline hydrate 225mg modified-release tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline hydrate 100mg modified-release tablets Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Amrinone Is a False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Ergotamine + caffeine Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Accidental phosphodiesterase inhibitor poisoning Causative agent True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier 2
Intentional phosphodiesterase inhibitor poisoning Causative agent True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier 2
Product containing precisely caffeine 65 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely caffeine 30 milligram and paracetamol 450 milligram/1 each conventional release oral tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing precisely caffeine 25 milligram and paracetamol 450 milligram/1 each conventional release oral tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing caffeine and paracetamol Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Paracetamol+caffeine 500mg/65mg soluble tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing caffeine and ergotamine Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Caffeine Is a True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Roflumilast Is a False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Substance with phosphodiesterase 4 inhibitor mechanism of action Is a True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Theophylline anhydrous Is a True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Theophylline sodium glycinate Is a True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Theophylline sodium acetate Is a True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Theophylline monohydrate Is a True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Theophylline calcium salicylate Is a True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Choline theophyllinate Is a True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Caffeine citrate Is a True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Caffeine hydrate Is a True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Milrinone lactate Is a False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Caffeine monohydrate Is a True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Papaverine Is a True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Papaveretum Is a True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Papaverine hydrochloride Is a True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Allergy to phosphodiesterase inhibitor Causative agent True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier 1
Amrinone lactate Is a False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Doxofylline Is a True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Substance with phosphodiesterase 3 inhibitor mechanism of action Is a True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Phosphodiesterase-5 inhibitor adverse reaction Causative agent False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 250mg/10ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Phyllocontin Paediatric Continus 100mg tablets (Napp Pharmaceuticals Ltd) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 250mg/10ml solution for injection ampoules (A A H Pharmaceuticals Ltd) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 100mg tablets (A A H Pharmaceuticals Ltd) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 250mg/10ml solution for injection ampoules (Unichem Plc) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Amnivent-225 SR tablets (Ashbourne Pharmaceuticals Ltd) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Norphyllin SR 225mg tablets (IVAX Pharmaceuticals UK Ltd) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Cafergot tablets (Alliance Pharmaceuticals Ltd) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Cafergot suppositories (Alliance Pharmaceuticals Ltd) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Minijet aminophylline 250mg/10ml solution for injection pre-filled syringes (Celltech Pharmaceuticals Ltd) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Panadol Extra soluble tablets (Haleon UK Ltd) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Hedex Extra tablets (GlaxoSmithKline Consumer Healthcare) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Panadol Extra tablets (Haleon UK Ltd) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 250mg/10ml solution for injection ampoules (hameln pharma Ltd) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Paracetamol Plus tablets (Zentiva Pharma UK Ltd) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Solpadeine Headache tablets (Haleon UK Ltd) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 225mg modified-release tablets (Unichem Plc) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline powder Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline powder (Synopharm GmbH & Co. KG) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline powder 100 gram Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline powder (Synopharm GmbH & Co. KG) 100 gram Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 250mg/10ml solution for injection ampoules (Goldshield Pharmaceuticals Ltd) Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 250mg/10ml solution for injection ampoules (Goldshield Pharmaceuticals Ltd) 10 ampoule Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 250mg/10ml solution for injection ampoules 10 ampoule Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline hydrate 350mg modified-release tablets 56 tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline hydrate 100mg modified-release tablets 56 tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 100mg tablets 28 tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline hydrate 225mg modified-release tablets 56 tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 225mg modified-release tablets 56 tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 225mg modified-release tablets 60 tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 250mg/10ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 100mg tablets (A A H Pharmaceuticals Ltd) 28 tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Phyllocontin Paediatric Continus 100mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) 56 tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 250mg/10ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule 10 x 10ml ampoules Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 250mg/10ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) 10 ampoule 10 x 10ml ampoules Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 250mg/10ml solution for injection ampoules (Unichem Plc) 10 ampoule 10 x 10ml ampoules Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Amnivent-225 SR tablets (Ashbourne Pharmaceuticals Ltd) 60 tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Norphyllin SR 225mg tablets (IVAX Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Minijet aminophylline 250mg/10ml solution for injection pre-filled syringes (Celltech Pharmaceuticals Ltd) 1 pre-filled disposable injection Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 250mg/10ml solution for injection ampoules (hameln pharma Ltd) 10 ampoule 2 x 5 x 10ml ampoules Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aminophylline 225mg modified-release tablets (Unichem Plc) 56 tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Panadol Extra tablets (Haleon UK Ltd) 8 tablet Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Roflumilast Is a False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Generic Otezla tablets treatment initiation pack Has active ingredient False Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Otezla tablets treatment initiation pack (Amgen Ltd) Has active ingredient True Substance with phosphodiesterase inhibitor mechanism of action Inferred relationship Existential restriction modifier

Start Page 2 of 2

This concept is not in any reference sets

Back to Start